Surgalign & NuVasive: How they line up in Q1

Spinal Tech

Medical technology companies Surgalign and NuVasive posted their first quarter financial results for 2023. 

Here is how they compare: 


Revenue: $16.7 million

Operating loss: $1.1 million 

Year-over-year revenue dip: $3.9 million


Sales: $307.7 million

Operating loss: $1 million

Year-over-year sales increase: $17 million

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers